| Retinitis pigmentosa: genes and disease mechanisms S Ferrari, E Di Iorio, V Barbaro, D Ponzin, F S Sorrentino, F Parmeggiani Current genomics 12 (4), 238-249, 2011 | 441 | 2011 |
| Mechanism of inflammation in age-related macular degeneration F Parmeggiani, MR Romano, C Costagliola, F Semeraro, C Incorvaia, ... Mediators of inflammation 2012, 2012 | 125 | 2012 |
| Good epidemiologic practice in retinitis pigmentosa: from phenotyping to biobanking M Chizzolini, A Galan, E Milan, A Sebastiani, C Costagliola, ... Current genomics 12 (4), 260-266, 2011 | 119 | 2011 |
| Aflibercept in wet AMD: specific role and optimal use F Semeraro, F Morescalchi, S Duse, F Parmeggiani, E Gambicorti, ... Drug design, development and therapy 7, 711, 2013 | 117 | 2013 |
| SSRIs and intraocular pressure modifications C Costagliola, F Parmeggiani, A Sebastiani CNS drugs 18 (8), 475-484, 2004 | 92 | 2004 |
| Inflammatory mediators and angiogenic factors in choroidal neovascularization: pathogenetic interactions and therapeutic implications C Campa, C Costagliola, C Incorvaia, C Sheridan, F Semeraro, ... Mediators of inflammation 2010, 2010 | 90 | 2010 |
| Selective serotonin reuptake inhibitors: a review of its effects on intraocular pressure C Costagliola, F Parmeggiani, F Semeraro, A Sebastiani Current neuropharmacology 6 (4), 293-310, 2008 | 81 | 2008 |
| Ocular surface changes induced by topical application of latanoprost and timolol: a short-term study in glaucomatous patients with and without allergic conjunctivitis C Costagliola, A Del Prete, C Incorvaia, R Fusco, F Parmeggiani, ... Graefe's archive for clinical and experimental ophthalmology 239 (11), 809-814, 2001 | 76 | 2001 |
| Therapeutic challenges to retinitis pigmentosa: from neuroprotection to gene therapy J N Sahni, M Angi, C Irigoyen, F Semeraro, M R Romano, F Parmeggiani Current genomics 12 (4), 276-284, 2011 | 73 | 2011 |
| Editorial [Hot Topic: Clinics, Epidemiology and Genetics of Retinitis Pigmentosa (Guest Editor: Francesco Parmeggiani)] F Parmeggiani Current genomics 12 (4), 236-237, 2011 | 71 | 2011 |
| Mechanism of inflammation in age-related macular degeneration: an up-to-date on genetic landmarks F Parmeggiani, FS Sorrentino, MR Romano, C Costagliola, F Semeraro, ... Mediators of inflammation 2013, 2013 | 67 | 2013 |
| Systemic thromboembolic adverse events in patients treated with intravitreal anti-VEGF drugs for neovascular age-related macular degeneration C Costagliola, L Agnifili, B Arcidiacono, S Duse, V Fasanella, ... Expert opinion on biological therapy 12 (10), 1299-1313, 2012 | 64* | 2012 |
| Topical nonsteroidal anti-inflammatory drugs for macular edema A Russo, C Costagliola, L Delcassi, F Parmeggiani, MR Romano, ... Mediators of inflammation 2013, 2013 | 56 | 2013 |
| Pharmacotherapy of intraocular pressure: part I. Parasympathomimetic, sympathomimetic and sympatholytics C Costagliola, R Dell'Omo, MR Romano, M Rinaldi, L Zeppa, ... Expert opinion on Pharmacotherapy 10 (16), 2663-2677, 2009 | 48 | 2009 |
| Reading performance in patients with retinitis pigmentosa: a study using the MNREAD charts G Virgili, C Pierrottet, F Parmeggiani, M Pennino, G Giacomelli, ... Investigative ophthalmology & visual science 45 (10), 3418-3424, 2004 | 48 | 2004 |
| Effect of 0.005% latanoprost once daily on intraocular pressure in glaucomatous patients not adequately controlled by beta-blockers twice daily: a 3-year follow-up C Costagliola, A Del Prete, M Verolino, P Antinozzi, R Fusco, ... Graefe's archive for clinical and experimental ophthalmology 240 (5), 379-386, 2002 | 45 | 2002 |
| Clinical and rehabilitative management of retinitis pigmentosa: up-to-date F Parmeggiani, G Sato, K De Nadai, M R Romano, A Binotto, ... Current genomics 12 (4), 250-259, 2011 | 43 | 2011 |
| Predictive role of coagulation-balance gene polymorphisms in the efficacy of photodynamic therapy with verteporfin for classic choroidal neovascularization secondary to age … F Parmeggiani, C Costagliola, D Gemmati, S D'Angelo, P Perri, ... Pharmacogenetics and genomics 17 (12), 1039-1046, 2007 | 43 | 2007 |
| Diabetic retinopathy and endothelin system: microangiopathy versus endothelial dysfunction FS Sorrentino, S Matteini, C Bonifazzi, A Sebastiani, F Parmeggiani Eye 32 (7), 1157-1163, 2018 | 39 | 2018 |
| Systemic adverse drug reactions secondary to anti-VEGF intravitreal injection in patients with neovascular age-related macular degeneration F Semeraro, F Morescalchi, F Parmeggiani, B Arcidiacono, C Costagliola Current vascular pharmacology 9 (5), 629-646, 2011 | 38 | 2011 |
